Most recent by Joshua D. Safer, MD, FACP, FACE
Data show some nonbinary people prefer lower testosterone doses
BOSTON — Most nonbinary people who initiated low-dose transdermal testosterone for gender affirmation continued taking doses that were lower than current guideline recommendations at 1 year, researchers reported at ENDO 2024.
Body composition changes at different stages of therapy for transgender boys vs. girls
Transgender girls see most of their body composition changes occur during puberty suppression, whereas transgender boys experience greater body composition changes during gender-confirming testosterone therapy, according to study data.
Q&A: Concepts, language surrounding gender care shift over past 20 years
For its 20th year in print, Endocrine Today is taking a look back at changes in endocrine gender care.
No association between gender-affirming hormone therapy, diabetes risk
Transgender people prescribed gender-affirming hormone therapy were no more likely to develop type 2 diabetes compared with cisgender adults, according to an analysis of electronic health records data.